Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Narhex Declares Bankruptcy; Involved in Xi’an JV

publication date: Feb 18, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Narhex Life Sciences, an Australian pharma whose main asset was a China joint venture, has declared bankruptcy. In 2006, Narhex and China Shaanxi Dacheng International Trading Co. established a JV to develop a protease inhibitor for HIV. It also had licensed China rights to Cavidi diagnostic products, which could measure HIV viral load. From the start, the goal was to develop the products for use in China. The JV, which was called Xi’an Hex Life Sciences Co., was supported by the Xi’an High Tech Authority. More details...



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners